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ABSTRACT
Introduction: Electronic prescribing systems can
improve the quality and safety of healthcare services,
but their implementation is not straightforward and
may create unexpected change. However, the added
complexity of paediatric prescribing (eg, dose
calculations, dilutions, manipulations) may pose
additional challenges. This study will aim to (1)
understand the complex organisational reality of a
paediatric hospital in which a new electronic paediatric
prescribing (ePP) system will be introduced; (2)
describe ePP-related change, over time, in paediatric
hospital ward settings; (3) explore staff perspectives in
relation to currently established practices and
processes; and (4) assess the impact of ePP on care
provision and hospital work from the perspective of
paediatricians, paediatric nurses and managers.
Methods and analysis: A qualitatively driven mixed-
method approach will be adopted, including 3 inter-
related substudies. The core component of the study
will be qualitative (substudy 1): we will use
ethnographic research methods, including non-
participant observation in wards and informal
conversational interviews with members of staff. In
addition, the design will include 2 embedded
supplementary components: a qualitative 1 (substudy
2) based on in-depth interviews and/or focus groups
with paediatricians, paediatric nurses, paediatric
pharmacists/pharmacy technicians and managers; and
a quantitative 1 (substudy 3) in which a staff survey
will be developed and administered before and after the
ePP implementation. Analytic themes will be identified
from ethnographic field notes and interview data.
Survey data will be analysed using descriptive statistics
and baseline and follow-up data compared to establish
impact evaluation measures.
Ethics and dissemination: A favourable ethical
opinion has been obtained from a National Health
Service (NHS) Research Ethics Committee (15/SS/
0157). NHS research governance approval has been
obtained at the relevant hospital site. The results of the
study will be disseminated through conferences and
peer-reviewed journals, as well as fed back to those
involved in clinical practice and policy development at
the study site.
INTRODUCTION
It has been widely acknowledged that the
introduction of new information and com-
munication technology in healthcare—or
Healthcare Information Technology (HIT)—
which usually implies full replacement of a
complex set of well-established practices,
Strengths and limitations of this study
▪ We will explore the impact of a new electronic
paediatric prescribing system before, during and
after its implementation. We are not aware of
similar longitudinal ethnographic studies.
▪ By describing and understanding how the imple-
mentation process unfolds over time, we also
expect to provide explanations relevant to quality
and safety outcomes.
▪ We will develop and test new measures of
impact drawing on health professionals’ and
managers’ perspectives.
▪ Key quantitative quality and safety outcomes
demonstrated in other studies and settings (such
as impact on medication error rates) will not be
measured as part of this study. However, other
studies in the same setting will cover these
aspects.
▪ The complexity specific to paediatric prescribing
and paediatric organisations might limit the
transferability of some of our findings.
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objects and interactions that have evolved over the years
—is not always free from critical and unintended
consequences.1
Despite the fact that the incorporation of new HIT is
often seen as a simple, safe, cheap and effective solution,
practical experience of HIT implementation shows how
the interplay between new HIT and existing conﬁgura-
tions and practices of healthcare work is complex and
may involve potentially disruptive effects or result in
emergent outcomes.2 Likewise, there is increased recog-
nition of the potential for technological interventions to
be compromised or fail if they do not integrate with
existing work.3 4 Examples of this can be found in
various areas such as telemedicine and e-health,5 tele-
phone triage expert systems,6 computer decision
support systems in emergency and urgent care,7 compu-
terised systems for the production of plans of care for
hospital inpatients8 or electronic medical record
technologies.9
As a new HIT, electronic prescribing (ePrescribing) or
Computerized Physician Order Entry Systems (CPOE)
has been identiﬁed as a means to improve quality and
safety in healthcare services delivery.10 11 However, it has
also been acknowledged that the implementation of
such systems is not straightforward and may create unex-
pected change—good or bad—once in use.12 Some of
these unintended and undesired consequences are
social in nature, with various potentially adverse effects
on clinical workﬂows13 and collaborative working11 such
as increased data entry tasks and redistribution of work
and time for patient care14 or reduced interactions
between nurses and doctors.15 As work practices change
hospital staff have to learn new ways of working, which
can also result in resistance to use HIT or the develop-
ment of ‘workarounds’ where technology is used in ways
other than intended.7 16 17 Examples of these can also
be found in recent contributions to the ﬁeld.11 18–20
In paediatrics, the need for calculations, dilutions and
manipulations of paediatric medicines, together with a
need to dose on an individual patient basis using age,
gestational age, weight and surface area, means that they
are more prone to medication errors at each stage of
the medicines management process.21 In recent years, a
growing body of evidence has contributed to the emer-
ging ﬁeld of electronic paediatric prescribing (ePP).22–26
Studies to date have largely focused on medication
errors,27 28 evaluation and response to medication
dosing alerts29 30 and on evaluating the potential of ePP
to reduce dosing and other medication errors.31 32
However, this does not preclude any organisation that
intends to implement ePP from facing similar challenges
to the ones already described in the wider arena of elec-
tronic prescribing or the even wider ﬁeld of HIT imple-
mentation. Therefore, there is still the need to identify
and address such challenges in the particular case of
ePP.
Inductive exploratory approaches of a qualitative
nature can make an important contribution to support
the implementation and development of ePrescribing
systems in speciﬁc contexts14 33 34 and have signiﬁcantly
contributed to inform initiatives such as the ePrescribing
Toolkit for National Health Service (NHS) Hospitals35
developed by the National Institute for Health Research
(NIHR)-funded ePrescribing Research Programme.
In particular, ethnographic studies have often identi-
ﬁed ‘hidden’ or less obvious aspects of ePrescribing
impacting on key issues such as quality and safety. For
instance, Swinglehurst et al36 identiﬁed the contribution
of receptionists and administrative staff to quality and
safety in repeat prescribing in the context of general
practices; Bossen and Markussen37 identiﬁed the cap-
acity of electronic prescribing devices to order informa-
tion, stipulate action and coordinate interaction; and
recently, Dixon-Woods et al38 identiﬁed the risk of focus-
ing attention on aspects of patient safety made visible by
electronic prescribing systems at the expense of other,
less measurable but nonetheless important, concerns.
An ethnographic approach to ePP implementation is
particularly well suited to explore the implications of
ePP on health professionals’ work practices. Informal
work practices are expected to vary, but assessing and
tracing changes and effects over time is likely to pay sig-
niﬁcant returns for the implementing organisation,
users and the quality of patient care.16 In addition,
ethnographic data may also yield valuable insights into
the organisational contextual factors39 of ePP and the
understanding of why errors happen and how new ePP
systems support the practices and processes underlying
such errors.40
Beyond that, as highlighted by Barber,12 a mixed-
method evaluation of electronic prescribing systems
allows the measurement of effects, together with an
understanding of why these effects are as they are, and
issues which need to be addressed to develop the system.
In keeping with the latter, and taking into account
recent ﬁndings and lessons learned from national and
international research on ePrescribing suggesting the
importance of process evaluations and the key role of
social and organisational factors, alongside the technical
characteristics of systems, in facilitating successful imple-
mentation of ePrescribing and other HIT,11 41 we
propose a qualitatively driven mixed-method process
and impact evaluation of the implementation of a new
ePP system in a paediatric hospital.
In particular, we will explore how this technology is
enrolled in everyday working practices in the ward
setting and how such practices change over time
through ethnographic research, complemented at
various stages by focus groups, interviews and question-
naires to enable a more encompassing identiﬁcation
and understanding of the social processes through
which ePP is brought into action. By understanding how
everyday working practices change, we expect to be able
to identify if, why and how the introduction of a new
ePP system impacts on healthcare delivery in the ward
setting.
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This study will be the ﬁrst ethnographic research to date
known to the authors on the implementation of
ePrescribing to explore the phenomenon before and over
time throughout the implementation process, and the ﬁrst
to be undertaken in a paediatric hospital in the UK.
We expect that such approach will enable us to identify
and examine a range of implications that still remain
unaddressed in paediatrics and which cannot be elicited
from sources such as audit data, routine metrics and statis-
tics or incident-reporting systems.42–44 The study will
engage with the production of ‘soft intelligence’44 in that
we will aim to address complex data about quality and
safety that cannot be straightforwardly classiﬁed and/or
quantiﬁed, particularly those that lie between acts of
recording/reporting and actual practices.38 42 45 46 In
doing so, we will also seek to consider whether or not key
issues raised by previous ethnographic research36–38 and
other qualitative studies in the ﬁeld of ePrescribing 14 33–35
may appear equally relevant, nuanced or absent in the
context of a paediatric organisation.
In addition, this study will contribute to a more
encompassing programme of work, which aims to assess
the realisation of the expected beneﬁts and outcomes of
ePP by integrating ﬁndings from this and two other
studies (one looking at key safety outcomes using
routine statistics, and another focusing on efﬁciency)
that will be undertaken alongside, but independently of,
this study at the same hospital site over approximately
the same period of time. In this context, we expect our
ﬁndings to provide explanations relevant to key out-
comes measured by these studies, as well as to contribute
new measures of impact drawing on health profes-
sionals’ and managers’ perspectives.
Aim and objectives
The overall aim of this study is to help improve the
quality and safety of healthcare delivery in paediatric
hospital ward settings by generating evidence to facilitate
the implementation of ePP in such settings.
Our objectives are:
1. To understand the complex organisational reality of a
paediatric hospital in which a new ePP will be
introduced.
2. To describe the nature of ePP-related change pro-
cesses by examining how practices and procedures
change, or are replaced, over time in paediatric hos-
pital ward settings as the system is implemented.
3. To explore staff perspectives (including paediatri-
cians, paediatric nurses, paediatric pharmacists/phar-
macy technicians and managers) in relation to
currently established practices and processes involved
in the prescribing and administration of medicines in
a paediatric hospital ward setting.
4. To assess the impact of implementing ePP on care
provision and hospital work in a paediatric hospital
ward setting from the perspective of paediatricians,
paediatric nurses and managers.
METHODS AND ANALYSIS
Design and data collection
To meet the aforementioned aims and objectives, we will
adopt a qualitatively driven mixed-method approach47 48
involving three inter-related substudies (ﬁgure 1).
A mixed-method design, in contrast to multimethod
research, consist of one project, known as the core
project, which is a complete method in itself, and a sup-
plemental strategy (or more than one) consisting of a
different type of data or analysis, that is not comprehen-
sible or interpretable apart from the core project.47
For our project, we will use an embedded design49
including a primary qualitative study and two embedded
supplementary substudies, qualitative and quantitative,
respectively (see ﬁgure 1).
Therefore, the rationale that will guide the conduct of
the study will draw on qualitative reasoning and the
overall theoretical drive will remain inductive.48 In this
context, quantiﬁcation and statistical analysis will play a
subordinate role to the overall interpretative framework
and thus contribute to the production of descriptions,
explanations and emerging theories.
Substudy 1 (primary qualitative component): understanding
change in the ward setting
As the primary component of our design, this qualitative
study will provide the overall rationale for the interpret-
ation of ﬁndings and will mainly contribute to meeting
objectives 1 and 2 by identifying, describing and understand-
ing how professionals’ interactions and practices are trans-
formed, or replaced, over time as ePP is implemented.
We will focus on how health professionals make the
prescribing and administration of medicines practically
workable in a changing organisational context and what
factors enable or inhibit the successful introduction of
ePP in a paediatric ward setting.
To do this, we will use ethnographic research
methods, including non-participant observation,50 infor-
mal conversational interviews51 and relevant documen-
tary data (eg, relevant ward documentation, hospital
policies, reports and guidance) will be collected where
appropriate. The foundations of our proposal engage
with grounded theory and ethnomethodology
approaches to ethnographic work.
Fieldwork will take place in three phases:
1. Before ePP implementation: The ﬁrst phase will take place
prior to the ePP implementation, involving approxi-
mately 150 h of observation over the past 4–5 months
before implementation/piloting of the system.
A. Primary focus: describing and understanding
the current set of practices and organisational
reality surrounding the prescribing and admin-
istration of medicines, as well as exploring the
social organisation of bringing paper-based pre-
scribing into action.
B. Data collection priorities:
i. Formal interviews will be conducted with
key informants, including ePP project leads
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Figure 1 Visual model of the design. EPP, electronic paediatric prescribing.
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in the hospital for medical, nursing, phar-
macy and IT areas, as well as any relevant
managers.
ii. We will shadow paediatricians (as they pre-
scribe medicines on the wards), paediatric
nurses (as they go about prescription
checking, preparation and administration
of medicines) and paediatric pharmacists/
pharmacy technicians (as they undertake
stock checks and drug charts checks on the
wards) across a general paediatric, a
general surgical and a highly specialised
ward.
iii. We will follow the course and use of paper
drug charts through the prescribing, prep-
aration and administration of medicines in
(or beyond) the ward settings.
iv. We will undertake textual analysis of key
documentary data, such as relevant hos-
pital policies and guidance documents.
2. During ePP implementation/piloting: The second phase
will take place during the implementation and/or
piloting of the new ePP system, involving approxi-
mately 100 h of observation.
A. Primary focus: exploring how everyday working
practices are transformed or replaced as ePP is
being implemented, as well as identifying emer-
ging problems and solutions.
B. Data collection priorities:
i. We will observe regular meetings of the
ePP implementation group (including
members from medical, nursing, pharmacy
and IT areas) as the system is piloted and
rolled out.
ii. We will shadow paediatric prescribers,
paediatric nurses, and paediatric pharma-
cists and pharmacy technicians as they
interact with the new ePP system and follow
the course of these practices through the
prescribing, preparation and administra-
tion of medicines in the pilot ward.
iii. Observations will include at least one non-
pilot ward to allow for comparisons and
identify any emerging aspects that can
facilitate/hinder the implementation.
3. After ePP implementation: The last phase will take place
after ePP is implemented in all wards, involving
approximately 100 h of observation over the follow-
ing 6 months after the system is rolled out in all
wards.
A. Primary focus: establishing how well the new
ePP system is integrated into (and sustained
through) everyday working practices.
B. Initial data collection priorities:
i. We will observe follow-up meetings of the
ePP implementation group (including
members from medical, nursing, pharmacy
and IT areas).
ii. We will undertake textual analysis of chan-
ging hospital policies and/or guidance
documents.
iii. We will shadow paediatric prescribers
(including medical and non-medical pre-
scribers, as they prescribe medicines on the
wards or remotely), paediatric nurses (as
they go about prescription checking, prep-
aration and administration of medicines)
and paediatric pharmacists/pharmacy tech-
nicians (as they undertake stock checks
and drug charts checks on the wards or
remotely) and observe how the new ePP
system is used in practice across the
observed wards.
Brieﬁng and debrieﬁng sessions with the research
team will be held before and after each data collection
session. Within each phase, data collection sessions will
take place in two separate rounds. After each round, the
researcher will engage in periods of more focused data
analysis and deﬁne the priorities for the next round of
data collection.
Alongside these phases, we will undertake a systematic
review of qualitative studies, which will further inform
the conduct of the study. However, a separate protocol
will be produced for this speciﬁc piece of work and will
be registered as appropriate.
Substudy 2 (supplementary qualitative component):
exploring staff perspectives on currently established
practices
This substudy will mainly contribute to meeting object-
ive 3, but also inform objectives 1 and 2, by eliciting and
analysing staff (including paediatric prescribers, paediat-
ric nurses, paediatric pharmacists/pharmacy technicians
and managers) views and experiences in relation to cur-
rently established practices and processes involved in the
prescribing and administration of medicines in the
ward, as well as their expectations, fears and basic
assumptions in relation to the new ePP system.
To do this, we will use qualitative methods, including
individual in-depth interviews52 and, where possible,
focus groups.53 54
Substudy 3 (supplementary quantitative component):
measuring impact of ePP on patient care and hospital work
in the ward setting
This substudy will mainly contribute to meeting object-
ive 4 by measuring the impact of ePP on hospital work
and patient care from the perspective of the staff
involved in care provision in the ward setting.
To do this, we will use a before-and-after design to
administer an online self-completion questionnaire,
aimed at measuring staff perceptions in relation to each
of the items included, to staff involved in the ward
setting.
The questionnaire will be developed based on: (1)
qualitative data emerging from substudy 2, which will
Farre A, Cummins C. BMJ Open 2016;6:e010444. doi:10.1136/bmjopen-2015-010444 5
Open Access
group.bmj.com on May 25, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
allow us to devise an instrument that measures meaning-
ful domains for the target population in an accessible
and inclusive way; (2) the hospital’s own working frame-
work of expected beneﬁts/outcomes; and (3) NHS
England guidance on the beneﬁts of ePrescribing.55
As a result, we expect the resulting set of items to
include a combination of:
▸ Expected practice-related outcomes (eg, Do paediatri-
cians and paediatric nurses feel their practice will be/
is safer?).
▸ Expected changes in working practices and proce-
dures (eg, Do paediatricians feel that remote access
will ease/has eased their workload?).
▸ Unexpected emerging issues (eg, Do paediatric
nurses feel that the technology will facilitate/facili-
tates their interaction with pharmacists and doctors to
check/amend prescriptions in a more timely
fashion?).
In addition, the resulting set of self-developed items
will be complemented by items from a measurement
instrument based on Normalization Process Theory
(NoMAD)56 in order to also measure other generic
aspects that can be associated with the implementation
process.
Experts in the ﬁeld will be asked to check the face
and content validity of the questionnaire. The reliability
of the questionnaire will be assessed through individual
interviews with 10 respondents after completion, in
which the survey questions will be repeated and the vari-
ance between written responses and the interview data
will be calculated. Difﬁcult or confusing questions will
be identiﬁed and discussed, as well as the clarity and
wording of the instructions. The questionnaire will be
amended where appropriate and then administered to
the rest of the sample, before and after the implementa-
tion of the new ePP system.
Participants and sampling
The overall sampling strategy will require the following
combination of non-random and random strategies:
In substudy 1, we will focus on those members of staff
directly or indirectly involved in the prescribing and
administration of medicines, in different shifts, in
selected wards. We will use a theoretical sampling strat-
egy57 minimising the differences between cases in the
ﬁrst instance, and then subsequently maximising the dif-
ferences between cases where possible, although inten-
sive care units and oncology wards will be excluded from
this study, due to their distinct dynamics and to avoid
overlaps with ongoing research speciﬁcally focusing on
such settings.
In substudy 2, we will focus on three groups of staff
directly involved in the prescribing and administration
of medicines in the ward (ie, doctors, nurses and phar-
macists) in addition to any relevant managerial roles. We
will use a purposive maximum variation sampling strat-
egy51 which involves sampling a wide range of cases to
get variation on dimensions of interest, which in this
case are types of wards and roles involved in the pre-
scribing and administration of medicines on the ward.
In substudy 3, we will focus on staff primarily involved
in direct patient care on the ward (ie, nurses, doctors
and other relevant health professionals) and staff pri-
marily involved in the organisation and functioning of
the ward (ie, ward managers and clerical staff). We will
use a stratiﬁed sampling strategy, which will allow us to
deﬁne groups that are homogeneous with respect to one
or more characteristics and then select a random sample
within each group.
As both substudies 1 and 2 will rely on purposive sam-
pling, the sample size should ideally be determined by
saturation, which is considered the gold standard by
which purposive sample sizes are determined.58
However, as an estimate for illustrative purposes, we can
anticipate a minimum sample of 2 wards and 30 infor-
mal interviews for substudy 1, and 6–12 interviews and
3–6 focus groups for substudy 2. As for substudy 3,
although sample size will be appropriately determined at
the early stages of the questionnaire design, following
the recommendations formulated by Borg and Gallo
(1989, cited in ref. 59), we estimate a sample size of
about 100 participants for the major subgrouping of the
survey (ie, staff primarily involved in direct patient care)
and 20–50 for minor subgroupings (ie, staff primarily
involved in the organisation and management of the
ward).
The overall inclusion/exclusion criteria are the
following:
▸ Inclusion criteria: members of staff; over the age of
18; able to give consent.
▸ Exclusion criteria: refusal of consent; unable to give
consent; withdrawal of consent.
Data analysis
Qualitative and quantitative data will be connected and
integrated at various stages. However, as we are using a
qualitatively driven design, the rationale for the overall
data analysis process and the interpretation of ﬁndings
will draw on qualitative reasoning.
Ethnographic ﬁeld notes will be anonymised and ana-
lytic themes will be identiﬁed, categorised and reﬁned
following the principles of the constant comparative
method60 and other procedures from ﬁrst-generation
grounded theory, such as coding and memoing.60 Data
collection and data analysis will take place concurrently,
so that issues raised in earlier rounds of ﬁeldwork can
be explored in subsequent ones, and analytic categories
subsequently reﬁned and further developed.
Documentary data collected during ethnographic ﬁeld-
work will be analysed using techniques from textual ana-
lysis.61 The coding and analysis process will be aided by
QSR NVivo V.10 software.
The overall data analysis will also be theoretically
informed by Normalization Process Theory (NPT)4 3 62
which is a sociological theory concerned with the social
organisation of the work (implementation), of making
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practices routine elements of everyday life (embedding),
and of sustaining embedded practices in their social
contexts (integration).62 The emerging coding frame-
work will be put into dialogue with the constructs of
NPT in order to enhance and expand the interpretative
framework in the light of an explanatory theory that
enables structured comparative inquiry and that there-
fore may facilitate the transferability of our ﬁndings to
other settings and cases.
Audio-recorded data from in-depth interviews and
focus groups will be transcribed verbatim, anonymised
and then subjected to thematic analysis.63 64 These ﬁnd-
ings will inform the design of the questionnaire and then
will be integrated into the overall qualitative data set.
Quantitative data from the baseline survey will be pro-
cessed, analysed using descriptive statistics and the
results used to expand or complement the interpret-
ation of qualitative data in subsequent rounds of data
analysis.65 Quantitative data from the follow-up survey
will be processed, integrated into the quantitative data
set and analysed. Baseline measures will then be com-
pared with follow-up measures to establish the resulting
impact evaluation measures. All statistical analyses will be
performed with IBM SPSS Statistics V.21 software.
ETHICS AND DISSEMINATION
Ethical considerations
The study received a favourable ethical opinion from an
NHS Research Ethics Committee (15/SS/0157), and
NHS research governance approval was obtained at the
relevant hospital site.
Patient and staff information sheets will be distributed
on the wards and clinical areas before and during the
observations. Before the observations, the researchers
will spend time on each selected ward across all shifts and
aim to be able to speak to the majority of staff to make
them aware of the observations, respond to any queries
about the study and hand them information sheets. In
addition, information sheets will be sent through the
Trust email, and posters announcing the observations will
be put on the selected wards before and during the
observation sessions. Participation in the study will be vol-
untary, and participants will be able to decline or with-
draw at any time. Where possible, the consent will be
written; however, there might be unexpected people at
the ward at the time of the observations from whom it
may not be possible to obtain consent in advance. In
such instances, we will seek verbal consent.
Although patient information will not be recorded/
considered for the study and parents/children are not
the subject of our observations, they both may be
present in a range of situations. In these instances, we
will prompt the relevant clinician to introduce the
researcher, who will then seek their verbal consent.
For the interviews, potential participants will be dir-
ectly approached by the researcher, who will hand them
the relevant information sheet. Written consent will be
sought after leaving at least 24 h to consider their
participation.
Finally, the questionnaire will be administered elec-
tronically and members of staff will initially be invited to
participate via email. An information sheet will be
included in the initial correspondence, and the consent
form will be available as the ﬁrst page of the online
survey. The contact details of the research team will be
provided with the initial correspondence and members
of staff will be free to contact a named researcher to
clarify the information given or request further
information.
Dissemination of findings
The study results will be disseminated through confer-
ences and peer-reviewed journals, as well as fed back to
those involved in clinical practice and policy develop-
ment at the study site, so that they can be better inte-
grated into routine clinical practice.
To this end, the study will incorporate a participatory
component which will combine engagement with (1)
key stakeholders at the hospital, and interested members
from (2) the Collaboration for Leadership in Applied
Health Research and Care (CLAHRC) West Midlands
patient and public involvement (PPI) advisory group;
(3) the hospital’s young people advisory group; and (4)
the hospital’s special interest group on ePrescribing.
This process will be operationalised through various dis-
cussion sessions, the frequency and dynamics of which
will be determined with the participants. We will aim to
discuss the ﬁndings before the end of each data analysis
phase of substudy 1 (ie, before, during and after imple-
mentation) as well as during and after the overall data
analysis phase (see ﬁgure 1). The purpose of these ses-
sions is twofold: on the one hand, we intend to use the
views of those involved to enhance and challenge our
coding framework and interpretation of the data. On
the other hand, we expect that the participation process
will increase the meaningfulness and encourage owner-
ship of the ﬁndings for those with responsibility for
implementation decisions as well as those affected by
the intervention.
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